Mayo T, Haderlein M, Schuster B, Wiesmueller A, Hummel C, Bachl M, Schmidt M, Fietkau R, Distel L (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 15
Journal Issue: 1
DOI: 10.1186/s13014-019-1444-4
Background Individual radiosensitivity is influencing the outcome of radiation therapy. A general ex vivo testing is very work-intensive. It is of interest to see if a significant prediction concerning the sensitivity can be made by in vivo irradiation during radiation treatment. Methods Blood samples of 274 patients with rectal cancer and 43 lung cancer patients receiving radiotherapy were examined after 2 Gy ex vivo and in vivo ionizing radiation. Chromosomes # 1, 2 and 4 were stained by the 3-color-fluorescence in situ hybridization. Chromosomal aberrations were analyzed as breaks per metaphase (B/M). The deposited energy per session was calculated for each patient. Results Weak correlation could be found between the chromosomal aberrations ex and in vivo. Though receiving significantly smaller deposited energy during radiation therapy (RT) the lung cancer cohort displayed B/M values similar to the rectal cancer cohort. Considering the individual deposit energy differences improved slightly the correlation. Conclusions As various factors influence the induction of chromosomal aberrations it seems not feasible to estimate individual radiosensitivity via in vivo irradiation. An ex vivo estimation of individual radiosensitivity should be preferred.
APA:
Mayo, T., Haderlein, M., Schuster, B., Wiesmueller, A., Hummel, C., Bachl, M.,... Distel, L. (2019). Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? Radiation Oncology, 15(1). https://doi.org/10.1186/s13014-019-1444-4
MLA:
Mayo, Theresa, et al. "Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?" Radiation Oncology 15.1 (2019).
BibTeX: Download